Judith Hochman
Circulation · 2000–2021
A researcher in the Science corpus: 42 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Who trusts Judith Hochman overall
Papers from Judith Hochman's perspective
Ordered by how strongly the researchers Judith Hochman trusts endorse each paper. Same corpus, a different order for every researcher.
- [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. (Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology)
- Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy (Circulation)
- Strategies for reducing the door-to-balloon time in acute myocardial infarction. (New England Journal of Medicine)
- Coronary intervention for persistent occlusion after myocardial infarction. (New England Journal of Medicine)
- AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. (Circulation)
- Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. (The Lancet)
- Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. (Journal of the American Medical Association (JAMA))
- The challenge of subgroup analyses--reporting without distorting.
- Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. (New England Journal of Medicine)
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. (The Lancet)
Their papers
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 (2021) — 704 citations
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021) — 686 citations
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 (2020) — 921 citations
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. (2020) — 741 citations
- Initial Invasive or Conservative Strategy for Stable Coronary Disease (2020) — 1,855 citations
- ST-Segment Elevation in Patients with Covid-19 — A Case Series (2020) — 686 citations
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2014) — 4,453 citations
- 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 1,670 citations
- Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. (2014) — 2,104 citations
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) — 709 citations
- 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 1,630 citations
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) — 3,872 citations
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) — 688 citations
- 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 743 citations
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013) — 3,746 citations
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) — 1,874 citations
- 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (2013) — 1,418 citations
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) — 3,814 citations
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 1,012 citations
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 597 citations